Thrombomodulin, a receptor for serine protease thrombin, is decreased in primary tumors and metastases but increased in ascitic fluids of patients with advanced ovarian cancer FIGO IIIc - Wilhelm,S.; Schmitt,M.; Parkinson,J.; Kuhn,W.; Graeff,H.; Wilhelm,O.G. (Int J Oncol, 1998)